CryoMedix said it’s raised $500,000 of a hoped-for $12 million Series B round for the cryoablation platform it’s developing.
San Diego-based CryoMedix is working on a device that uses single-phase liquid coolants, a feedback system, disposable catheter/needles and a rechargeable cartridge system to ablate tissue, according to its website.